Table 2.
Type | Pathogen | Number of events |
---|---|---|
Virus | CMV | 53 |
VZV | 7 | |
HSV‐1/2 | 6 | |
EBV | 24 | |
HHV‐6 | 8 | |
Rotavirus | 2 | |
BK virus | 10 | |
JC virus | 3 | |
RSV | 2 | |
Parainfluenza virus | 1 | |
H1N1 influenza | 3 | |
Coronavirus | 1 | |
Rhinovirus | 1 | |
Adenovirus | 1 | |
HBV | 1 | |
Bacteria | Escherichia coli | 25 |
Pseudomonas aeruginosa | 8 | |
Stenotrophomonas maltophila | 2 | |
Enterococcus faecalis | 5 | |
Enterococcus faecium | 4 | |
Staphylococcus coagulase‐negative | 18 | |
Streptococcus pneumoniae | 6 | |
Staphylococcus aureus | 8 | |
Clostridium difficile | 7 | |
Mycoplasma pneumoniae | 1 | |
Acinetobacter baumanii | 2 | |
Corynebacterium species | 2 | |
Enterobacter cloacae | 1 | |
Fungi | Aspergillus | 6 |
Candida, non‐albicans | 5 |
CMV, cytomegalovirus; VZV, varicella zoster virus; HSV, herpes simplex virus; EBV, Epstein–Barr virus; HHV‐6, human herpesvirus type 6; RSV, respiratory syncytial virus; HBV, hepatitis B virus.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.